Skip to main content
Erschienen in: Archives of Gynecology and Obstetrics 1/2018

23.10.2017 | General Gynecology

The growth of uterine myomas in untreated women: influence factors and ultrasound monitoring

verfasst von: Robert Armbrust, Klaus-Dieter Wernecke, Jalid Sehouli, Matthias David

Erschienen in: Archives of Gynecology and Obstetrics | Ausgabe 1/2018

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Until now there are no systematic studies about the long-term course of myoma growth. Therefore, the aims of the present study were: (1) ultrasound monitoring of the natural course of growth of uterine leiomyomas; (2) assessment of whether the growth of myomas depends on the age of the patients, the location, or the initial size (possible co-factors/predictor criteria for increase of growth); influence of oral contraceptives (OC).

Methods

Patient records (2010–May 2016) were retrospectively and systematically evaluated in regards to their growth and clinical course. The patients received a follow-up questionnaire by mail about the further history. Linear regression analysis and generalized regression analysis were performed to determine the influence of various factors on the growth of myomas.

Results

Overall, 152 met the further inclusion criteria. Most of the myomas increased in size but 10% of the myomas became smaller without therapy. There is a significant dependency between the initial myoma size, and the first and second measurements, but not between those measures and myoma localization. In regression analysis, there was also a significant association between the growth of the myomas and the initial size but no association with age, complaint symptoms, and use of OC. However, the use of OC waas significantly associated with myoma growth in GEE.

Conclusions

The course of growth of myomas has large variance, so this should not be taken as a sign for a malignant event (sarcoma or the so-called STUMP). The growth takes place with considerable individual variability and ultimately is not predictable.
Literatur
1.
Zurück zum Zitat Reis M, Bloise M, Ortiga-Carvalho TM (2015) Hormones and pathogenesis of uterine fibroid. Best Pract Res Clin Obstet Gynaecol 34(13–24):25 Reis M, Bloise M, Ortiga-Carvalho TM (2015) Hormones and pathogenesis of uterine fibroid. Best Pract Res Clin Obstet Gynaecol 34(13–24):25
2.
Zurück zum Zitat Sparic R, Mirkovic L, Malvasi A, Tinelli A (2016) Epidemiology of uterine myomas: a review. Int J Fertil Steril 9:424–435PubMed Sparic R, Mirkovic L, Malvasi A, Tinelli A (2016) Epidemiology of uterine myomas: a review. Int J Fertil Steril 9:424–435PubMed
3.
Zurück zum Zitat Fleischer R, Weston GC, Vollenhoven BJ, Rogers PA (2008) Pathophysiology of fibroid disease: angiogenesis and regulation of smooth muscle proliferation. Best Pract Res Clin Obstet Gynaecol 22(4):603–614CrossRefPubMed Fleischer R, Weston GC, Vollenhoven BJ, Rogers PA (2008) Pathophysiology of fibroid disease: angiogenesis and regulation of smooth muscle proliferation. Best Pract Res Clin Obstet Gynaecol 22(4):603–614CrossRefPubMed
4.
Zurück zum Zitat Downes E, Sikirica V, Gilabert-Estelles J, Bolge SC, Dodd SL, Maroulis C et al (2010) The burden of uterine fibroids in five European countries. Eur J Obstet Gynecol Reprod Biol 152:96–102CrossRefPubMed Downes E, Sikirica V, Gilabert-Estelles J, Bolge SC, Dodd SL, Maroulis C et al (2010) The burden of uterine fibroids in five European countries. Eur J Obstet Gynecol Reprod Biol 152:96–102CrossRefPubMed
6.
Zurück zum Zitat Istre O (2008) Management of symptomatic fibroids: conservative surgical treatment modalities other than abdominal or laparoscopic myomectomy. Best Pract Res Clin Obstet Gynaecol 22:735–747CrossRefPubMed Istre O (2008) Management of symptomatic fibroids: conservative surgical treatment modalities other than abdominal or laparoscopic myomectomy. Best Pract Res Clin Obstet Gynaecol 22:735–747CrossRefPubMed
7.
Zurück zum Zitat Ichimura T, Kawamura N, Ito F, Shibata S, Minakuchi K, Tsujimura A, Umesaki N, Ogita S (1998) Correlation between the growth of uterine leiomyomata and estrogen and progesterone receptor content in needle biopsy specimens. Fertil Steril 70:967–971CrossRefPubMed Ichimura T, Kawamura N, Ito F, Shibata S, Minakuchi K, Tsujimura A, Umesaki N, Ogita S (1998) Correlation between the growth of uterine leiomyomata and estrogen and progesterone receptor content in needle biopsy specimens. Fertil Steril 70:967–971CrossRefPubMed
8.
Zurück zum Zitat Peddada SD, Laughlin SK, Miner K, Guyon JP, Haneke K, Vahdat HL et al (2008) Growth of uterine leiomyomata among premenopausal black and white women. Proc Natl Acad Sci USA 105:19887–19892CrossRefPubMedPubMedCentral Peddada SD, Laughlin SK, Miner K, Guyon JP, Haneke K, Vahdat HL et al (2008) Growth of uterine leiomyomata among premenopausal black and white women. Proc Natl Acad Sci USA 105:19887–19892CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Davis BJ, Haneke KE, Miner K, Kowalik A, Barrett JC, Peddada S, Baird DD (2009) The fibroid growth study: determinants of therapeutic intervention. J Woments Health 18:725–732CrossRef Davis BJ, Haneke KE, Miner K, Kowalik A, Barrett JC, Peddada S, Baird DD (2009) The fibroid growth study: determinants of therapeutic intervention. J Woments Health 18:725–732CrossRef
10.
Zurück zum Zitat Kasai M, Ichimura T, Kawamura N, Sumikura T, Matsuda M, Asano C, Sumi T, Ishiko O (2012) Prediction of the shrinking rate of uterine leiomyoma nodules using needle biopsy specimens. Fertil Steril 98:440–443CrossRefPubMed Kasai M, Ichimura T, Kawamura N, Sumikura T, Matsuda M, Asano C, Sumi T, Ishiko O (2012) Prediction of the shrinking rate of uterine leiomyoma nodules using needle biopsy specimens. Fertil Steril 98:440–443CrossRefPubMed
11.
Zurück zum Zitat Tsuda H, Kawabata M, Nakamoto O, Yamamoto K (1998) Clinical predictors in the natural history of uterine leiomyoma: preliminary study. J Ultrasound Med 17:17–20CrossRefPubMed Tsuda H, Kawabata M, Nakamoto O, Yamamoto K (1998) Clinical predictors in the natural history of uterine leiomyoma: preliminary study. J Ultrasound Med 17:17–20CrossRefPubMed
12.
Zurück zum Zitat DeWaay DJ, Syrop CH, Nygaard IE, Davis WA, Van Voorhis BJ (2002) Natural history of uterine polyps and leiomyomata. Obstet Gynecol 100:3–7PubMed DeWaay DJ, Syrop CH, Nygaard IE, Davis WA, Van Voorhis BJ (2002) Natural history of uterine polyps and leiomyomata. Obstet Gynecol 100:3–7PubMed
13.
Zurück zum Zitat Mavrelos D, Ben-Nagi J, Holland T, Hoo W, Naftalin J, Jurkovic D (2010) The natural history of fibroids. Ultrasound Obstet Gynecol 35:238–242CrossRefPubMed Mavrelos D, Ben-Nagi J, Holland T, Hoo W, Naftalin J, Jurkovic D (2010) The natural history of fibroids. Ultrasound Obstet Gynecol 35:238–242CrossRefPubMed
14.
Zurück zum Zitat Brölmann H, Tanos V, Grimbizis G, Ind T, Philips K, van den Bosch T, on behalf of the European Society of Gynaecological Endoscopy (ESGE) steering committee on fibroid morcellation et al (2015) Options on fibroid morcellation: a literature review. Gynecol Surg 12:3–15CrossRefPubMedPubMedCentral Brölmann H, Tanos V, Grimbizis G, Ind T, Philips K, van den Bosch T, on behalf of the European Society of Gynaecological Endoscopy (ESGE) steering committee on fibroid morcellation et al (2015) Options on fibroid morcellation: a literature review. Gynecol Surg 12:3–15CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Exacoustos C, Romanini ME, Amadio A, Amoroso C, Szabolcs B, Zupi E, Arduini D (2007) Can gray-scale and color Doppler sonography differentiate between uterine and leiomyoma? J Clin Ultrasound 35:449–457CrossRefPubMed Exacoustos C, Romanini ME, Amadio A, Amoroso C, Szabolcs B, Zupi E, Arduini D (2007) Can gray-scale and color Doppler sonography differentiate between uterine and leiomyoma? J Clin Ultrasound 35:449–457CrossRefPubMed
16.
Zurück zum Zitat Baird DD, Garrett TA, Laughlin SK, Davis B, Semelka RC, Peddada SD (2011) Short-term change in growth of uterine leiomyoma: tumor growth spurts. Fertil Steril 95:242–246CrossRefPubMed Baird DD, Garrett TA, Laughlin SK, Davis B, Semelka RC, Peddada SD (2011) Short-term change in growth of uterine leiomyoma: tumor growth spurts. Fertil Steril 95:242–246CrossRefPubMed
17.
Zurück zum Zitat Malartic C, Morel O, Rivain AL, Placé V, Le Dref O, Dohan A, Gayat E, Barranger E, Soyer P (2013) Evaluation of symptomatic uterine fibroids in candidates for uterine artery embolization: comparison between ultrasonographic and MR imaging findings in 68 consecutive patients. Clin Imaging 37:83–90CrossRefPubMed Malartic C, Morel O, Rivain AL, Placé V, Le Dref O, Dohan A, Gayat E, Barranger E, Soyer P (2013) Evaluation of symptomatic uterine fibroids in candidates for uterine artery embolization: comparison between ultrasonographic and MR imaging findings in 68 consecutive patients. Clin Imaging 37:83–90CrossRefPubMed
18.
Zurück zum Zitat Ciarmela P, Islam MS, Reis FM, Gray PC, Bloise E, Petraglia F, Vale W, Castellucci M (2011) Growth factors and myometrium: biological effects in uterine fibroid and possible clinical implications. Hum Reprod Update 17:772–790CrossRefPubMedPubMedCentral Ciarmela P, Islam MS, Reis FM, Gray PC, Bloise E, Petraglia F, Vale W, Castellucci M (2011) Growth factors and myometrium: biological effects in uterine fibroid and possible clinical implications. Hum Reprod Update 17:772–790CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Commandeur AE, Styer AK, Teixeira JM (2015) Epidemiological and genetic clues for molecular mechanisms involved in uterine leiomyoma development and growth. Hum Reprod Update 21:593–615CrossRefPubMedPubMedCentral Commandeur AE, Styer AK, Teixeira JM (2015) Epidemiological and genetic clues for molecular mechanisms involved in uterine leiomyoma development and growth. Hum Reprod Update 21:593–615CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Markowski DN, Holzmann C, Bullerdiek J (2015) Genetic alterations in uterine fibroids—a new direction for pharmacological intervention? Expert Opin Ther Targets 19(11):1485–1489CrossRefPubMed Markowski DN, Holzmann C, Bullerdiek J (2015) Genetic alterations in uterine fibroids—a new direction for pharmacological intervention? Expert Opin Ther Targets 19(11):1485–1489CrossRefPubMed
Metadaten
Titel
The growth of uterine myomas in untreated women: influence factors and ultrasound monitoring
verfasst von
Robert Armbrust
Klaus-Dieter Wernecke
Jalid Sehouli
Matthias David
Publikationsdatum
23.10.2017
Verlag
Springer Berlin Heidelberg
Erschienen in
Archives of Gynecology and Obstetrics / Ausgabe 1/2018
Print ISSN: 0932-0067
Elektronische ISSN: 1432-0711
DOI
https://doi.org/10.1007/s00404-017-4568-5

Weitere Artikel der Ausgabe 1/2018

Archives of Gynecology and Obstetrics 1/2018 Zur Ausgabe

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.